Lanzamiento Enero 2027

Ensayo controlado aleatorizado2013Acceso abierto

Effects of wheat and oat-based whole grain foods on serum lipoprotein size and distribution in overweight middle aged people: a randomised controlled trial

Tighe P, Duthie G, Brittenden J, Vaughan N, Mutch W, Simpson WG, Duthie S, Horgan GW, Thies F

PloS one · 12 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación independiente

Según la declaración de financiación del texto completo.

Publicación

Publicado
2013-08-05 · PLoS One · vol. 8 · número 8 · pág. e70436
Editorial
Public Library of Science
Citado
16 citas · más que el 71% de estudios similares · 0.7× el promedio de su campo
Referencias
49 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Food composition and properties · Nutritional Studies and Diet · Seed and Plant Biochemistry
Palabras clave
Medicine, Overweight, Lipoprotein, Lipoprotein(a), Avena, Refined grains, Obesity, Whole grains, Blood lipids, Internal medicine, Physiology, Animal science, Food science, Cholesterol, Biology, Agronomy
MeSH
humans, triticum, lipoproteins, adult, aged, middle aged, female, male, overweight, avena

9 autores

  • Paula Tighe🇬🇧University of Aberdeen
  • Garry G. Duthie🇬🇧University of Aberdeen
  • Julie Brittenden🇬🇧University of Aberdeen
  • Nicholas J. Vaughan🇬🇧University of Aberdeen
  • William James Mutch🇬🇧National Health Service; NHS Grampian
  • William G. Simpson🇬🇧National Health Service; NHS Grampian
  • Susan J. Duthie🇬🇧University of Aberdeen
  • Graham William Horgan🇬🇧Biomathematics and Statistics Scotland
  • Frank Thiès🇬🇧 · autor de correspondenciaUniversity of Aberdeen

Resumen

El texto original del estudio, en el idioma en que se publicó.

Introduction

Epidemiological studies suggest three daily servings of whole-grain foods (WGF) might lower cardiovascular disease risk, at least partly by lowering serum lipid levels. We have assessed the effects of consuming three daily portions of wholegrain food (provided as wheat or a mixture of wheat and oats) on lipoprotein subclass size and concentration in a dietary randomised controlled trial involving middle aged healthy individuals.

Methods

After a 4-week run-in period on a refined diet, volunteers were randomly allocated to a control (refined diet), wheat, or wheat + oats group for 12 weeks. Our servings were determined in order to significantly increase the intakes of non starch polysaccharides to the UK Dietary Reference Value of 18 g per day in the whole grain groups (18.5 g and 16.8 g per day in the wheat and wheat + oats groups respectively in comparison with 11.3 g per day in the control group). Outcome measures were serum lipoprotein subclasses' size and concentration. Habitual dietary intake was assessed prior and during the intervention. Of the 233 volunteers recruited, 24 withdrew and 3 were excluded.

Results

At baseline, significant associations were found between lipoprotein size and subclasses' concentrations and some markers of cardiovascular risk such as insulin resistance, blood pressure and serum Inter cellular adhesion molecule 1 concentration. Furthermore, alcohol and vitamin C intake were positively associated with an anti-atherogenic lipoprotein profile, with regards to lipoprotein size and subclasses' distribution. However, none of the interventions with whole grain affected lipoprotein size and profile.

Conclusion

Our results indicate that three portions of wholegrain foods, irrelevant of the type (wheat or oat-based) do not reduce cardiovascular risk by beneficially altering the size and distribution of lipoprotein subclasses.

Trial registration

www.Controlled-Trials.com ISRCTN 27657880.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.